Jane Street
DCPH

Jane Street’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Jane Street’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,900
Closed -$326K – 10197
2022
Q4 		$326K Sell
19,900
-2,000
-9% -$32.5K ﹤0.01% 6875
2022
Q3 		$405K Sell
21,900
-8,200
-27% -$129K ﹤0.01% 7069
2022
Q2 		$396K Buy
30,100
+9,000
+43% +$99.3K ﹤0.01% 7150
2022
Q1 		$196K Sell
21,100
-112,300
-84% -$955K ﹤0.01% 9045
2021
Q4 		$1.3M Buy
133,400
+117,300
+729% +$2.21M ﹤0.01% 5375
2021
Q3 		$547K Buy
+16,100
New +$514K ﹤0.01% 7116
2021
Q2 		– Sell
-9,100
Closed -$408K – 10584
2021
Q1 		$408K Buy
9,100
+3,200
+54% +$149K ﹤0.01% 7164
2020
Q4 		$337K Buy
+5,900
New +$350K ﹤0.01% 6254

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Jane Street's DCPH Position: Q2 2024 in Review

Jane Street sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 14,779 shares — an estimated $232K sold.

Jane Street first reported a position in DCPH in Q2 2018 and held it in 17 quarters. The position peaked at $1.48M in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Jane Street reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jane Street sold 14,779 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $232K.
  • Jane Street first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 17 quarters.
  • Jane Street's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.48M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.